P1326: FACTORS ASSOCIATED WITH THE OUTCOME OF ALLO-HSCT FOR ADVERSE-CYTOGENETIC RISK ACUTE MYELOID LEUKEMIA

HemaSphere (Jun 2022)

Affiliations

J. M. Cerezo-Martin: 1 Hematology, Marques de Valdecilla University Hospital, santander
A. Avendaño: 2 Hematology, Salamanca University Hospital, Salamanca, Spain
S. Fernandez-Luis: 1 Hematology, Marques de Valdecilla University Hospital, santander
J. A. Calvo: 1 Hematology, Marques de Valdecilla University Hospital, santander
E. Ocio: 1 Hematology, Marques de Valdecilla University Hospital, santander
M. Colorado: 1 Hematology, Marques de Valdecilla University Hospital, santander
A. Bermudez: 1 Hematology, Marques de Valdecilla University Hospital, santander

Abstract

No abstracts available.

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://onlinelibrary.wiley.com/journal/25729241